<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148977</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201602508</org_study_id>
    <nct_id>NCT03148977</nct_id>
  </id_info>
  <brief_title>Evaluating MMPs in Burns</brief_title>
  <official_title>Evaluating a Point-of-Care, Quantitative Matrix Metalloproteinase Assay as a Predictor of Successful Graft Take in Patients Undergoing Cutaneous Auto Grafting for Acute Burn Injury- A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine whether our chemical assay can be used to
      reliably predict graft take or failure in patients undergoing autologous skin grafting for
      treatment of acute burn injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational pilot study of patients treated at UF Health Shands Burn Center
      adult service. This is a study to determine the predictive value of quantifying
      concentrations of specific MMPs. Coupling this with a specialized collection sample
      collection system and a calibrated fluorimetry allows for the rapid assessment of MMP
      concentrations. This assay has been validated as a predictor of failed wound healing in a
      published clinical study involving chronic open wounds.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predictability of graft take</measure>
    <time_frame>2 years</time_frame>
    <description>Determine whether chemical assay can be used to reliably predict graft take or failure in patients undergoing autologous skin grafting for treatment of acute burn injury.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound healing</measure>
    <time_frame>2 years</time_frame>
    <description>Assess the predictive value of serial MMP assays in identifying wounds transitioning from likely-to-fail to likely-to-succeed</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Burns</condition>
  <condition>Thermal Burn</condition>
  <condition>Thermal Injury</condition>
  <arm_group>
    <arm_group_label>Patients admitted to the burn center</arm_group_label>
    <description>Patients admitted to the Burn Service with acute burn injuries requiring at least one surgical excision and grafting operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Graft</intervention_name>
    <description>Autogenous skin grafting is the only definitive treatment for the full thickness burn injuries, and thus represents the centerpiece of modern burn care.</description>
    <arm_group_label>Patients admitted to the burn center</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Acute burn wound exudate Acute burn wound tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult burn patients admitted
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  Admitted with acute burns injuries (flame, contact or scald) requiring at least one
             surgical excision and grafting operation will be considered for inclusion

          -  Burn injury less than one week old

        Exclusion Criteria:

          -  Electrical, chemical or cold-induced burn injury

          -  Total body surface area burn &gt;50 %

          -  Pre injury diagnosis of chronic renal insufficiency, liver failure, refusal to accept
             blood transfusion or withdrawal of care within three days of admission will also be
             exclusion criteria

          -  Patients not expected to survive

          -  Patients presenting with re-injury to previously burned and treated areas.

          -  Patients who present after receiving burn excision surgery out an outside facility for
             the current acute injury
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>98 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua S. Carson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joshua S. Carson, MD</last_name>
    <phone>(352) 273-5670</phone>
    <email>Joshua.carson@surgery.ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tera G. Thigpin</last_name>
    <phone>(352) 273-5670</phone>
    <email>Tera.thigpin@surgery.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UF Health Cancer Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua S. Carson, MD</last_name>
      <phone>352-273-5670</phone>
      <email>Joshua.carson@surgery.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tera G. Thigpin</last_name>
      <phone>(352) 273-5670</phone>
      <email>Tera.thigpin@surgery.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Joshua S. Carson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David W. Mozingo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Schultz, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Gibson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UF Health Shands at the University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua S. Carson, MD</last_name>
      <phone>352-273-5670</phone>
      <email>Joshua.carson@surgery.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tera G. Thigpin</last_name>
      <phone>(352) 273-5670</phone>
      <email>Tera.thigpin@surgery.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Joshua S. Carson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David W. Mozingo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Schultz, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Gibson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>May 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Matrix Metalloproteinases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

